Pharma companies are facing pricing pressure from several directions, including from the U. S. Medicare negotiations.
administrator
PGIM Jennison Focused Value Fund Q3 2025 Commentary
NBA Expands Illegal Gambling Investigation: What To Know
The cull, spurred by bird flu concerns, aims to eradicate 400 ostriches living on a farm in...
With less than three weeks until the November election, there are concerns tonight that thousands of voter...
